RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recce Pharmaceuticals Stock

Recce Pharmaceuticals Liabilities 2024

Recce Pharmaceuticals Liabilities

15.89 M AUD

Ticker

RCE.AX

ISIN

AU000000RCE5

WKN

A2ADQM

In 2024, Recce Pharmaceuticals's total liabilities amounted to 15.89 M AUD, a 520.31% difference from the 2.56 M AUD total liabilities in the previous year.

Recce Pharmaceuticals Aktienanalyse

What does Recce Pharmaceuticals do?

Recce Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Recce Pharmaceuticals's Liabilities

Recce Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Recce Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Recce Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Recce Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Recce Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Recce Pharmaceuticals stock

What is the level of liabilities of Recce Pharmaceuticals this year?

Recce Pharmaceuticals has a debt balance of 15.89 M AUD this year.

What were the liabilities of Recce Pharmaceuticals compared to the previous year?

The liabilities of Recce Pharmaceuticals have increased by 520.31% increased compared to the previous year.

What are the consequences of high debt for investors of Recce Pharmaceuticals?

High liabilities can pose a risk for investors of Recce Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Recce Pharmaceuticals?

Low liabilities mean that Recce Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Recce Pharmaceuticals affect the company?

An increase in liabilities of Recce Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Recce Pharmaceuticals affect the company?

A decrease in the liabilities of Recce Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Recce Pharmaceuticals?

Some factors that can influence the liabilities of Recce Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Recce Pharmaceuticals so important for investors?

The liabilities of Recce Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Recce Pharmaceuticals take to modify the liabilities?

To change its liabilities, Recce Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Recce Pharmaceuticals pay?

Over the past 12 months, Recce Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Recce Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Recce Pharmaceuticals?

The current dividend yield of Recce Pharmaceuticals is .

When does Recce Pharmaceuticals pay dividends?

Recce Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Recce Pharmaceuticals?

Recce Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Recce Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Recce Pharmaceuticals located?

Recce Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recce Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recce Pharmaceuticals from 9/24/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/24/2024.

When did Recce Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/24/2024.

What was the dividend of Recce Pharmaceuticals in the year 2023?

In the year 2023, Recce Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Recce Pharmaceuticals pay out the dividend?

The dividends of Recce Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recce Pharmaceuticals

Our stock analysis for Recce Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recce Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.